1. National Comprehensive Cancer Network. Colon Cancer (Version 4.2020). Available at: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 11 Sep 2020.
2. Morton DL, Ollila DW, Hsueh EC, Essner R, Gupta RK. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. CA Cancer J Clin. 1999;49(2):101–16. https://doi.org/10.3322/canjclin.49.2.101.
3. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40(2):256–60.
4. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery. 1985;98(3):414–22.
5. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Annals Surg. 1995;221(2):124–32. https://doi.org/10.1097/00000658-199502000-00002.